Clinical Trial Update: A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early [Phase 2]

View source ↗

Summary

This Phase 2 translational clinical trial in breast cancer aims to use molecular markers and functional imaging to predict response to preoperative therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Thomas Hatschek | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN